On May 20, 2022, Quest Diagnostics Incorporated announced that at its annual general meeting of shareholders held on May 18, 2022, the stockholder proposal regarding the right to call special meetings of stockholders was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.9 USD | -0.84% | -3.16% | -8.68% |
Apr. 11 | John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission | CI |
Apr. 05 | Quest Diagnostics Receives Shareholder Proposal from John Chevedden | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.68% | 13.98B | |
-12.12% | 87.46B | |
+9.72% | 78.56B | |
+10.85% | 29.37B | |
-12.25% | 16.78B | |
-5.06% | 16.01B | |
+1.87% | 12.31B | |
-30.00% | 12.07B | |
+20.38% | 11.06B | |
-4.03% | 11.4B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Declaration of Voting Results by Quest Diagnostics Incorporated